Melinda Taschetta-Millane, Editorial Director
Melinda Taschetta-Millane, Editorial Director
Blog | Melinda Taschetta-Millane, Editorial Director | Women's Health| October 03, 2017

The Role of Personalized Breast Cancer Screening

The Role of Personalized Breast Cancer Screening

It is once again October, Breast Cancer Awareness Month. The American Cancer Society (ACS) estimates that about 252,710 new cases of invasive breast cancer and 63,410 new cases of carcinoma in situ (CIS) will be diagnosed in 2017. About 40,610 women will die from breast cancer this year.

Only lung cancer beats out breast cancer in women for the leading cause of cancer deaths, and the chance that a woman will die from breast cancer is about 1 in 37, or about 2.7 percent, according to the ACS. Since 2007, breast cancer death rates have been steady in women younger than 50, but have continued to decrease in older women. These decreases are attributed to the result of earlier and better screening procedures and treatments.

Having the topic of breast density in the limelight has also helped to raise awareness, and as of this month, and thanks to many, many hours of dedicated work from industry lobbyists, 30 states now require some level of patient density notification, according to densebreast-info.org.

Monica Saini, M.D., medical director — ABUS at GE Healthcare, says it’s an exciting time to be a breast radiologist “because we no longer have to prescribe to a one-size-fits-all screening exam,” she said in the itnTV video “Innovative Breast Cancer Screening for Women with Dense Breast Tissue.” In it, she discusses the advancements for women in personalized breast care, and how automated breast ultrasound (ABUS) helps meet the challenges of screening and diagnostic imaging of dense breast tissue.

“Instead of prescribing to this system, we can use a multimodality approach to individualize each woman’s breast care,” she explained, stating that the industry now has new tools, like risk assessment, and knows to look at the personal history of each patient, her family history of cancer and her personal biology, which is best demonstrated by breast density. “Using these tools together, we can come up with an individualized plan for each patient. We start with the gold standard of screening mammography.

“Now we have new advancements in technology with tomosynthesis that allows us to reduce the callback rate,” she continued. “But we have even newer technologies like automated breast ultrasound which allow us to screen dense breasted patients, which is about 40 percent of the population. When we use these tools together, we have a synergistic type of effect. So the magic is we find more cancer. And that’s the ultimate goal for a breast radiologist is to increase our cancer detection rate but decrease our false positives. New technology has given us game-changing applications that can be applied to breast imaging.”

You can watch the full video with Saini at http://bit.ly/2jI6KF2. In this issue, ITN is premiering its automated breast ultrasound systems comparison chart. You can review the system specs from participating companies on page 47
of this issue.

Related Content

In a demonstration on the exhibit floor of the SBI symposium, Koios software identified suspicious lesions in ultrasound images

In a demonstration on the exhibit floor of the SBI symposium, Koios software identified suspicious lesions in ultrasound images. Photo by Greg Freiherr

Feature | Artificial Intelligence | April 19, 2019 | By Greg Freiherr
Commercial efforts to develop...
Videos | Breast Imaging | April 18, 2019
In a keynote lecture at the Society of Breast Imaging (SBI)/American College of Radiology (ACR) 2019 Symposium, ...
Fatty tissue and breast density may be considered in the context of many factors that affect the occurrence and detection of breast cancer

Fatty tissue and breast density may be considered in the context of many factors that affect the occurrence and detection of breast cancer. Permission to publish provided by DenseBreast-info.org

Feature | Breast Imaging | April 18, 2019 | By Greg Freiherr
When planning a screening program to detect the early signs of breast cancer, age is a major consideration.
iCAD Appoints Stacey Stevens as President
News | Radiology Business | April 16, 2019
iCAD Inc. recently announced that Stacey Stevens has been named president. As president, Stevens will have expanded...
compressed breast during mammography.
360 Photos | 360 View Photos | April 16, 2019
A 360 view of a simulated breast compression for a...
A smart algorithm has been trained on a neural network to recognize the appearance of breast cancer in MR images

A smart algorithm has been trained on a neural network to recognize the appearance of breast cancer in MR images. The algorithm, described at the SBI/ACR Breast Imaging Symposium, used “Deep Learning,“ a form of machine learning, which is a type of artificial intelligence. Graphic courtesy of Sarah Eskreis-Winkler, M.D.

Feature | Artificial Intelligence | April 12, 2019 | By Greg Freiherr
The use of smart algorithms has the potential to make healthcare more efficient.
This image depicts ABUS images with QVCAD results

This image depicts ABUS images with QVCAD results.

Feature | Breast Imaging | April 12, 2019
Imaging Technology News spoke with Bob Foley, vice president of sales and marketing of QView Medical, Inc.,
Uterine Fibroid Embolization Safer and as Effective as Surgical Treatment
News | Interventional Radiology | April 05, 2019
Uterine fibroid embolization (UFE) effectively treats uterine fibroids with fewer post-procedure complications compared...